Hydroxycitric acid tripotassium hydrate, CAS [[6100-05-6]]
Artikelnummer:
BYT-ORB1309565
- Bilder (0)
| Artikelname: | Hydroxycitric acid tripotassium hydrate, CAS [[6100-05-6]] |
| Artikelnummer: | BYT-ORB1309565 |
| Hersteller Artikelnummer: | orb1309565 |
| Alternativnummer: | BYT-ORB1309565-1,BYT-ORB1309565-10,BYT-ORB1309565-5,BYT-ORB1309565-500 |
| Hersteller: | Biorbyt |
| Kategorie: | Biochemikalien |
| Alternative Synonym: | ACLY, 1534146, ATPCitrateLyase, ATP, ATP Citrate Lyase, ATP citrate lyase, anti-inflammation, antioxidation, Bacterial, cleavage, CaOx, Citrate, inhibit, extramitochondrial, Hypoxia-inducible factors, Hydroxycitric acid tripotassium, Hydroxycitric acid tripotassium hydrate, Hydroxycitric acid tripotassium Hydrate, Inhibitor, HIFs, HIFProlylHydroxylase, HIF, HIF ProlylHydroxylase, HIF Prolyl-Hydroxylase, HIF-PH, HIF-1alpha, HIF/HIF ProlylHydroxylase, HIF/HIF Prolyl-Hydroxylase, HIF/HIFProlylHydroxylase, Potassium citrate, Potassium Citrate, Potassium citrate Monohydrate, Potassium citrate monohydrate, stones, safety |
| Potassium citrate monohydrate, a derivative of citric acid and key component of Garcinia cambogia, acts as an ATP-citrate lyase inhibitor. It is applied in research exploring nephrolithiasis prevention, metabolic studies for weight management, and investigations into its HIF-inhibitory, antioxidant, and anti-inflammatory properties in cellular and animal models. |
| Molekulargewicht: | 324.41 |
| Reinheit: | 99.85% (May vary between batches) |
| CAS Nummer: | [6100-05-6] |
| Formel: | C6H7K3O8 |
| Target-Kategorie: | Apoptosis,ATP Citrate Lyase,HIF/HIF Prolyl-Hydroxylase,Antibacterial,Endogenous Metabolite,HIF |
| Anwendungsbeschreibung: | Solubility: DMSO:2.49 mg/mL (7.68 mM) |
